Oncology and Hematology

Episodes 81-93 of 93

• 

  MinuteCE®

  RWE Where RCTs Fall Short: Optimizing Frontline Treatment of HR+/HER2- Metastatic Breast Cancer

  0.75 credits 7 episodes

  • 

    

    Adam Brufsky, MD, PhD

  • 

    

    Christopher M. Gallagher, MD

  0.75 credits 7 episodes

• 

  RestartResume

  Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects

  RestartResume

  Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects

  MinuteCE®

  Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects

  0.75 program credits

  • 

    

    Christopher M. Gallagher, MD

  • 

    

    Adam Brufsky, MD, PhD

  0.75 program credits

• 

  RestartResume

  Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective

  RestartResume

  Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective

  MinuteCE®

  Real World Use of RWE in HR+ Metastatic Breast Cancer: The Oncologist Perspective

  0.75 program credits

  • 

    

    Adam Brufsky, MD, PhD

  • 

    

    Christopher M. Gallagher, MD

  0.75 program credits

• 

  RestartResume

  Case Study: Treatment Sequencing in Platinum-Resistant Relapse ES-SCLC

  RestartResume

  Case Study: Treatment Sequencing in Platinum-Resistant Relapse ES-SCLC

  MinuteCE®

  Case Study: Treatment Sequencing in Platinum-Resistant Relapse ES-SCLC

  1.50 program credits

  • 

    

    Ticiana Leal, MD

  • 

    

    Jacob Sands, MD

  1.50 program credits

• 

  RestartResume

  Case: Peri-Operative Immunotherapy in Early-Stage NSCLC

  RestartResume

  Case: Peri-Operative Immunotherapy in Early-Stage NSCLC

  MinuteCE®

  Case: Peri-Operative Immunotherapy in Early-Stage NSCLC

  1.00 program credit

  • 

    

    Joshua E. Reuss, MD

  • 

    

    Jessica S. Donington, MD, MSCR

  1.00 program credit

• 

  RestartResume

  Case Study: Treatment Sequencing in Platinum-Sensitive Relapse ES-SCLC 

  RestartResume

  Case Study: Treatment Sequencing in Platinum-Sensitive Relapse ES-SCLC 

  MinuteCE®

  Case Study: Treatment Sequencing in Platinum-Sensitive Relapse ES-SCLC 

  1.50 program credits

  • 

    

    Ticiana Leal, MD

  • 

    

    Jacob Sands, MD

  1.50 program credits

• 

  MinuteCE®

  ES-SCLC: Sequencing Strategies in Previously Treated Patients 

  1.50 credits 5 episodes

  • 

    

    Ticiana Leal, MD

  • 

    

    Jacob Sands, MD

  1.50 credits 5 episodes

• 

  RestartResume

  Panel Discussion: Patient Selection, Emerging Studies and Strategies in ES-SCLC

  RestartResume

  Panel Discussion: Patient Selection, Emerging Studies and Strategies in ES-SCLC

  MinuteCE®

  Panel Discussion: Patient Selection, Emerging Studies and Strategies in ES-SCLC

  1.50 program credits

  • 

    

    Ticiana Leal, MD

  • 

    

    Jacob Sands, MD

  1.50 program credits

• 

  RestartResume

  Case Study: Managing Common Adverse Events Associated with Second-Line Treatment of ES-SCLC

  RestartResume

  Case Study: Managing Common Adverse Events Associated with Second-Line Treatment of ES-SCLC

  MinuteCE®

  Case Study: Managing Common Adverse Events Associated with Second-Line Treatment of ES-SCLC

  1.50 program credits

  • 

    

    Ticiana Leal, MD

  • 

    

    Jacob Sands, MD

  1.50 program credits

• 

  RestartResume

  Case: Update of Neoadjuvant Therapies for Resectable Lung Cancer

  RestartResume

  Case: Update of Neoadjuvant Therapies for Resectable Lung Cancer

  MinuteCE®

  Case: Update of Neoadjuvant Therapies for Resectable Lung Cancer

  1.00 program credit

  • 

    

    Joshua E. Reuss, MD

  • 

    

    Jessica S. Donington, MD, MSCR

  1.00 program credit

• 

  RestartResume

  Case: Adjuvant Immunotherapy in Localized NSCLC

  RestartResume

  Case: Adjuvant Immunotherapy in Localized NSCLC

  MinuteCE®

  Case: Adjuvant Immunotherapy in Localized NSCLC

  1.00 program credit

  • 

    

    Joshua E. Reuss, MD

  • 

    

    Jessica S. Donington, MD, MSCR

  1.00 program credit

• 

  RestartResume

  Case Study: Sequencing Therapy in ES-SCLC in Special Patient Populations

  RestartResume

  Case Study: Sequencing Therapy in ES-SCLC in Special Patient Populations

  MinuteCE®

  Case Study: Sequencing Therapy in ES-SCLC in Special Patient Populations

  1.50 program credits

  • 

    

    Ticiana Leal, MD

  • 

    

    Jacob Sands, MD

  1.50 program credits

• 

  MinuteCE®

  Earlier Use of ICIs in NSCLC: Integrating the Latest Evidence Into Clinical Practice

  1.00 credit 3 episodes

  • 

    

    Jessica S. Donington, MD, MSCR

  • 

    

    Joshua E. Reuss, MD

  1.00 credit 3 episodes